The relatively low success rates for bio/pharmaceutical compounds in clinical development have prompted many organizations to explore ways of reducing risk in clinical development.
Denise Calaprice-Whitty
Advertisement
Articles by Denise Calaprice-Whitty
Advertisement
Latest Updated Articles
Managing Clinical Development Risk: Pharma and CRO ReportPublished: February 1st 2014 | Updated:
Advertisement
Advertisement
Trending on Pharmaceutical Technology
1
Using AI and Molecular Dynamics to Overcome the Poor Solubility Challenge
2
Why Context Matters in Validating Biomarker Assays for Bioanalysis
3
Targeted high resolution metabolite screening workflows
4
Application of alternative electron-based fragmentation for identification of drug metabolites and quantification of complex peptide therapeutics
5
